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Abstract
Objectives Multidetector CT (MDCT) is a valuable tool for
functional prosthetic heart valve (PHV) assessment. However,
radiation exposure remains a concern. We assessed a novel
CT-acquisition protocol for comprehensive PHV evaluation
at limited dose.
Methods Patients with a PHV were scanned using a third-
generation dual-source CT scanner (DSCT) and iterative re-
construction technique (IR). Three acquisitionswere obtained:
a non-enhanced scan; a contrast-enhanced, ECG-triggered,
arterial CT angiography (CTA) scan with reconstructions at
each 5 % of the R-R interval; and a delayed high-pitch CTA of
the entire chest. Image quality was scored on a five-point
scale. Radiation dose was obtained from the reported CT dose
index (CTDI) and dose length product (DLP).
Results We analysed 43 CTexaminations. Mean image quality
score was 4.1±1.4, 4.7±0.5 and 4.2±0.6 for the non-contrast-
enhanced, arterial and delayed acquisitions, respectively, with a
total mean image quality of 4.3±0.7. Mean image quality for
leaflet motion was 3.9±1.4. Mean DLP was 28.2±17.1, 457.3
±168.6 and 68.5±47.2 mGy.cm for the non-contrast-enhanced
(n=40), arterial (n=43) and delayed acquisition (n=43), respec-
tively. The mean total DLP was 569±208 mGy.cm and mean
total radiation dose was 8.3±3.0 mSv (n=43).
Conclusion Comprehensive assessment of PHVs is possible
using DSCT and IR at moderate radiation dose.
Key points
• Prosthetic heart valve dysfunction is a potentially life-
threatening condition.
• Dual-source CT can adequately assess valve leaflet motion
and anatomy.
• We assessed a comprehensive protocol with three acquisi-
tions for PHVevaluation.
• This protocol is associated with good image quality and
limited dose.
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Abbreviations
CTA Computed tomography angiography
DSCT Dual-source computed tomography
IR Iterative reconstruction
MDCT Multidetector computed tomography
PHV Prosthetic heart valve
PVL Paravalvular leakage
TEE Transoesophageal echocardiography
TTE Transthoracic echocardiography
Introduction
Prosthetic heart valve (PHV) dysfunction is an uncommon
but important and potentially life-threatening complication
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after PHV implantation [1]. In daily practice, the most com-
monly used imaging modality for evaluating PHVs is trans-
thoracic echocardiography (TTE) [2]. TTE has known lim-
itations such as a high interobserver variability, the possi-
bility of poor acoustic windows and acoustic shadowing.
Hence, evaluation of PHVabnormalities often also requires
transoesophageal echocardiography (TEE), which is a
semi-invasive procedure associated with certain risks and
complications, and is also affected by some of the TTE
limitations, albeit to a lesser extent [3].
More recently, multidetector computed tomography
(MDCT) has been shown to provide complementary infor-
mation for PHV assessment and is useful to identify the
cause of PHV dysfunction, including obstructive masses
(such as pannus and thrombus), prosthesis-patient mis-
match, paravalvular regurgitation, as well as infective endo-
carditis and its complications [4, 5]. Most often, a retrospec-
tively ECG-gated CT angiography (CTA) acquisition is
used to assess PHV dysfunction since it allows for recon-
structions at each 5–10 % of the R-R interval needed to
dynamically assess valve leaflet motion and anatomy.
Such acquisitions are associated with a relatively high radi-
ation dose as reported in multiple studies (mean 11.6 mSV
[interquartile range (IQR) 10.8–14.4], 11.8 mSV [IQR
11.2–12.8] and 18.8 ±3.8 mSV [IQR 6, 7, 8]). Ideally, a
CTacquisition protocol for PHVassessment would not only
include a dynamic CTA but also a non-enhanced scan of the
valve region to assess calcifications and suture pledgets, as
well as a delayed phase of the entire chest for possible ab-
scesses, septic pulmonary emboli and overall thoracic anat-
omy, which would increase radiation dose even further [9].
Third-generation dual-source scanners allow for several
dose-reduction strategies that are advantageous for PHV
assessment. We examined whether a novel, moderate radi-
ation dose three-phase CT acquisition protocol for third-
generation dual-source CT (DSCT) allows comprehensive
ECG-triggered PHV assessment with both static and dy-
namic reconstructions to assess the PHV region as well as
the entire chest.
Materials and methods
Patients
All consecutive patients with a PHV that underwent a CT can
with this specific acquisition protocol in our department be-
tween December 2014 and November 2016 were included.
The acquisition was a part of the routine clinical workup,
and data were gathered retrospectively. No additional acquisi-
tions were made specifically for this study. Patient data were
retrieved from the electronic patient files. A waiver for
retrospective evaluation of the data was obtained from the
medical ethics committee.
CT scan protocol
Image acquisition was performed on a third-generation DSCT
(SOMATOM Force, Siemens, Erlangen, Germany). Image
acquisition included three consecutive scans (Table 1, Fig. 1).
First, a non-enhanced prospectively ECG-triggered scan of
the PHV region alone was performed with the following ac-
quisition parameters: fixed tube voltage 120 kV, reference
effective tube load 80 mAs, collimation adapted to fit scan
length, and gantry rotation time 250 ms. Data were acquired
and reconstructed (slice thickness 3 mm, increment 3 mm,
Qr36 kernel) for the 45 % phase of the R-R interval with
iterative reconstruction (IR) (Admire Level 3, Siemens).
Secondly, a prospectively ECG-triggered wide-pulsing
window sequential CT angiography (CTA) was performed
with the following parameters: fixed tube voltage of 120 kV,
reference effective tube load 180 mAs, collimation 192 ×
0.6 mm and gantry rotation time of 250ms. This prospectively
ECG-triggered sequential scan was made with three, five or
seven stacks. Care was taken to centre the middle stack on the
prosthetic valve to avoid any stack artefacts at the level of the
valve. For three stacks, the scan length in the z-axis was set at
14 cm, to allow for a maximum coverage per stack in the
longitudinal direction (Figs. 2 and 3). Reducing the scan
length will reduce the coverage of each of the three stacks
evenly until the coverage can be accommodated by two
stacks, thereby increasing the risk of stack artefacts. For this
CTA, we used an ECG-trigger based on an absolute delay time
after an R-peak instead of a relative (%) R-R trigger delay.
Irrespective of heart rate, a fixed ‘scan-on–scan-off’ padding
setting from 0–1,500 ms with 50–500 ms ECG-pulsing was
used, which resulted in a scan acquisition window that is
guaranteed to provide the fastest onset of radiation after an
R-peak. After 500 ms, tube current (and thus radiation) de-
creased from 100 % to 20 % of the set level. Radiation was
then maintained for 1,500 ms (which is a full heart cycle at 40
bpm) or cut off when the next R-peak occurred.
Reconstructions were made at each 5 % of the R-R interval,
with a slice thickness of 0.75mm, an increment of 0.4 mm and
Bv40 kernel (Figs. 2 and 3). An iterative reconstruction tech-
nique was used (Admire level 3, Siemens).
Thirdly and finally, a low-dose high-pitch CTA of the entire
chest was performed, which was triggered in such a way that
the scan reaches the trachial carina level at 30 % of the R-R
interval. The scan was made with the following parameters:
automatically selected tube voltage, reference effective tube
load 180 mAs at 120 kV, collimation 192 × 0.6 mm, and a
pitch of 3.2. Reconstructions were made with an increment of
0.4 mm, a slice thickness of 0.75 mm in Bv40 kernel and
iterative reconstruction (Admire level 3, Siemens).
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A single biphasic contrast administration protocol was used in
which a total amount of 100 ml of contrast was given with an
Iodine concentration of 320 mg/ml (Visipaque 320®, GE
Healthcare, Cork, Ireland). First, 80 ml of contrast was injected
at a rate of 5.0 ml/s, followed by 20ml of contrast at 3.5 ml/s and
a saline flush of 25 ml at 2.5 ml/s. A region of interest was
defined in the ascending aorta and data acquisitionwas initialized
when the threshold of 100 HU was reached. The delayed acqui-
sition was obtained 70 s after contrast injection. No beta blockers
or nitroglycerin were administered since they may be contraindi-
cated in patients with valvular pathology.
Radiation dose was obtained from the reported CT dose index
(CTDI) and dose length product (DLP) and converted to an
effective dose, using a conversion factor of 0.0145 mSv/
mGy*cm [10]. Heart rate during the acquisitions was obtained
from the automatically generated information stored with the
DICOM images.
Image analysis
Assessment of the CT examinations was performed on a ded-
icated workstation (Philips Intellispace Portal, v6.0.3.12200).
Using multiplanar reformation, images were reconstructed in
plane with the PHV and perpendicular to the PHV and valve
leaflets. Cine mode was used to dynamically evaluate PHV
leaflet motion in all reconstructed phases of the RR interval.
Image quality was scored separately for each of the three
acquisitions in the same way, using a 5-point scale, adapted
from a 4-point scoring system used in a previous study by our
group [11]. The criteria for the different scores were formulat-
ed as follows: 1 – no discernible detail, no diagnostic infor-
mation can be obtained; 2 – only limited visualization of the
region of interest, no accurate measurements can be made; 3 –
image quality is moderate, measurements and diagnosis are
possible; 4 – image quality is good, no diagnostic or
Table 1 Prosthetic heart valve scan protocol
Prosthetic valve protocol Non-enhanced scan Contrast-enhanced, ECG-triggered, CTA Delayed high-pitch CTA of the entire chest
Scan start 2 cm above valve Center of scan centered 2 cm above arch
Scan end 2 cm below valve On valve Bottom of heart
Scan length Variable Fixed 14 cm (3 stacks) Variable
Scan type Prospective step and shoot Prospective step and shoot Prospective high pitch spiral flash
Collimation Adapted to scan length 192 x 0.6 mm 192 x 0.6 mm
Rotation time (ms) 250 250 250
Pitch n.a. n.a. 3.2
Feed/rot (mm) variable 48 184
Reference mAs/rot 80 180 180
mA modulation Yes, CARE DOSE 4D Yes, CARE DOSE 4D Yes, CARE DOSE 4D
Reference kVp 120 120 120
kVp modulation CARE kV semi 120 CARE kV semi 120 CARE kV semi 120
Tissue of interest Non-contrast Vascular Vascular
Beta blocker/Nitrates no no no
ECG padding 45 %–45 % 0–1,500 ms n.a.
ECG pulsing off 50–500 ms n.a.
Contrast no yes yes
Type Iodixanol*320mgl/ml
Bolus 80 ml at 5 ml/s
Chaser (30 % mix ratio) 20 ml at 3.5 ml/s
delay Bolustracking 70 s post-injection
Slice width (mm) 3.0 0.75 0.75
Slice increment (mm) 3.0 0.4 0.4
Kernel Qr36 Bv40 Bv40
ADMIRE strength 3 3 3
ECG phase % 45 % 10–100 % at 5 % interval 30 % at trachial carina level
ECG phase ms n.a. Best systolic ms phase by computer n.a.
*Visipaque, GE Healthcare
CTA CT angiography
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measurement problems; 5 – image quality is excellent.
Furthermore, image quality of PHV leaflet motion was scored
in the same way: 1 – leaflet motion not assessable; 2 – leaflet
motion assessable, no reliable measurements can be made; 3 –
leaflet motion assessable with the ability to measure opening
and closing angles; 4 – good image quality of the leaflet
Fig. 1 Image acquisition
includes three sequential
acquisitions: A non-contrast-
enhanced scan (A); a contrast-
enhanced arterial CTangiography
(CTA) with reconstructions at
each 5 % of the R-R interval (B);
and a delayed high pitch CTA of
the entire chest (C), which allows
for evaluation of the complete
thoracic aorta as shown on this
sagittal view (D)
Fig. 2 CTangiography (CTA) acquisition: Effect of scan range length in
CTA:With prospective protocols in third-generation dual-source CTA the
collimation is adapted to the set scan length. In regular cardiac
examinations, this helps to avoid overscanning and results in an
interpatient variability of the coverage per stack. When scanning heart
valves full heart coverage is not always necessary and a shorter rangemay
be sufficient. Special care should be taken in planning the scan range,
however, so the largest possible z coverage per stack is obtained to avoid
stack artefacts at the valve level. A A short scan range consisting of two
stacks will result in potential stack artefacts through the valve. B A
slightly longer scan range will result in three thin collimate stacks with
the valve in the middle of the mid stack. Heart motion and respiratory
variability might still move the valve into the potential stack artefacts. C
Opening the scan length to exactly 14 cm will result in three stacks with
maximum stack coverage ensuring valve images without ECG stack
artefacts
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motion; 5 – excellent assessment of leaflet motion possible.
Scoring was performed by two radiologists (RB andMF) who
had 10 and 2 years of experience with cardiac CT, respective-
ly. The best image quality phase for assessing PHV could be
variable among patients. Therefore, for each acquisition, the
best cardiac phase was selected for scoring image quality. All
images were clinically assessed for PHV-related pathology
such as paravalvular leakage, thrombus and/or pannus forma-
tion, left ventricular outflow tract (LVOT) obstruction and
abscesses.
Data analysis
Descriptive statistics were used to analyse the study data.
Mean values and standard deviations were calculated.
Interobserver variability was analysed by weighted kappa sta-
tistics based on Cohen’s statistic.
Results
Patient characteristics
A total of 43 CT examinations acquired in 41 patients were
included (mean age 60±23 years, 22 males). One patient who
was imaged on three separate occasions was included three
times. PHVs were positioned in the aortic (n=35), mitral (n=6)
and pulmonary position (n=3). One patient had two PHVs. Of
all 44 PHVs examined, 21 were mechanical valves and 23
were biological valves (Table 2). The main indications for
referral were suspicion or follow-up of endocarditis (n=22),
increased pressure gradient or suspicion of valve obstruction
(n=10), suspicion or follow-up of paravalvular leakage (n=4).
Other indications were follow-up after coarctation repair
(n=2), after tetralogy of Fallot repair (n=1), follow-up of
Marfan’s disease (n=1), after a Bentall procedure (n=1), after
closure of a pseudo-aneurysm (n=1) and newly diagnosed
pleural effusion(n=1).
CT parameters
The non-enhanced acquisition was not performed in three pa-
tients. In all other patients (n=40), the three acquisitions were
obtained. Mean heart rate during scanning was 70±19 bpm for
the non-enhanced scan, 69±13 bpm for the ECG-triggered
CTA and 75±25 bpm for the high-pitch CTA. Heart rate var-
iability was calculated for the different stacks of the non-
contrast-enhanced scan and the CTA, using 1 standard devia-
tion of the mean heart rate. This was 2.3 bpm for the non-
contrast-enhanced scan and 2.8 bpm for the CTA. The maxi-
mum heart rate variability was 24 bpm for the non-enhanced
scan and 32.3 bpm for the CTA. The number of stacks used
was 1 (n=10), 2 (n=23), 3 (n=5) and 4 (n=2) for the non-
enhanced scan and 3 (n=41), 5 (n=1) and 7 (n=1) for the
ECG-triggered CTA. Stack artefacts were seen in one out of
30 non-contrast enhanced CT scans (ten non-contrast scans
were scanned with only one stack, so artefacts could not oc-
cur) and in two out of 43 ECG-triggered CTAs. In all these
examinations, the artefacts did not appear at the valve posi-
tion. In the delayed acquisition with automatic tube voltage
selection, in one of 43 scans (2 %) the reference voltage of
120 kV was chosen, in three scans (7 %) the tube voltage was
Fig. 3 Screenshot from scanner console: The ECG-trigger in this CTA
acquisition is based on absolute millisecond (ms) time instead of a relative
(%) RR-trigger. A ‘scan-on–scan-off’ padding setting from 0–1,500 ms
with 50–500 ms ECG-pulsing results in a scan acquisition window that is
guaranteed to provide the fastest onset of radiation after an R-peak
(minimum delay is ±100 ms, which is 10 % at 60 bpm). Radiation is
maintained for 1,500 ms (which is a full heart cycle at 40 bpm) or is cut
off when the next R-peak occurs. This means that independent of the heart
rate, a full heart cycle (starting from 100 ms) is guaranteed
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100 kV, in four scans (9 %) 70 kV, in nine scans (21 %) 90 kV
and in most of the scans (26 scans, 61 %) 80 kV was chosen.
Radiation dose
Mean CTDI was 3.13±1.28, 30.92±9.6 and 2.31±0.94 mGy
for the non-enhanced (n=40), CTA (n=43) and delayed acqui-
sitions (n=43), respectively. Mean DLP was 28.2±17.1, 457.3
±168.6 and 68.5±47.2 mGy.cm for the non-contrast-enhanced
(n=40), arterial (n=43) and delayed acquisition (n=43), re-
spectively. The mean total DLP was 569±208 mGy.cm.
Mean total radiation dose was 8.3±3.0 mSv (range 3–17,
n=43) (Table 3). In one study, the arterial CTA had seven
stacks, with a wider scan range due to coronary artery bypass
grafting (CABG), which resulted in a total dose of 16.7 mSv.
In two studies, the abdomen was included in the high-pitch
acquisition with a total radiation dose of 16.8 mSv and 6.7
mSv, respectively. Furthermore, one study had an additional
high-pitch acquisition with a total radiation dose of 12.7 mSv.
Image quality scores
The mean image quality score was 4.1±1.4, 4.7±0.5 and 4.2
±0.6 for the non-enhanced, arterial CTA and delayed acquisi-
tion, respectively, with a total mean image quality of 4.3±0.7
(Fig. 4). Mean image quality for leaflet motion was 3.9±1.4.
Only one non-enhanced scan had a score of 1 and was not
interpretable due to the presence of a cobalt- and chromium-
containing mechanical heart valve (Björk-Shiley valve),
which gives substantial artefacts. Another non-enhanced scan
had a score of 2 with limited image quality due to a too short
scan length with incomplete visualization of the heart.
Overall, 124 out of 126 (98 %) acquisitions (40 non-con-
trast-enhanced, 43 CTA and 43 delayed acquisitions) had an
image quality score of ≥ 3. Regarding leaflet motion, four
scans had a score of 1 and were non-diagnostic and four had
a score of 2 with only poor image quality. These were five
transcatheter valves (four Corevalves and one Sapien valve)
and three conventional biological valves. Thirty-four scans
had an image quality score of ≥ 3 (81%) with respect to leaflet
motion.
Out of 43 examinations, 16 showed no PHV-related abnor-
malities. Five examinations revealed a false aneurysm at the
aortic root. Three examinations showed a clear paravalvular
leakage (PVL) and four had possible PVL (Fig. 5). Five ex-
aminations showed pannus or thrombus under the PHV and
six examinations showed vegetations/structures inside the
PHV. Abscess formation was found in one examination.
Five examinations showed a cavity under the PHV. Three
examinations revealed thrombus in the left atrial appendage.
On the other hand, two patients had suboptimal filling of the
left atrial appendage at the CTA, but thrombus could be ex-
cluded with the delayed scan.
Interobserver agreement
The weighted kappa value for the image quality scores of both
observers was 0.74 for the non-contrast-enhanced scan, 0.87
for the CTA and 0.80 for the delayed high-pitch scan. For
scoring image quality of leaflet motion the kappa value was
Table 2 Patient characteristics
Gender (n=41) 22 male 19 female
Age, years (mean) (n=41) 60±23
PHV position (n=44) Aortic: 35 Mitral: 6 Pulmonary: 3
PHV type (n=44) Mechanical: 21 Biological: 12 TAVI: 11
St-Jude: 19 Perimount: 6 Corevalve: 6
Carbomedics: 1 Sorin: 1 Lotus: 3
Björk-Shiley: 1 Perigon: 1 Sapien: 2
Homograft: 4
PHV prosthetic heart valve
Table 3 Radiation dose
overview of the different
acquisitions
Non-contrast CT scan (mean±SD) Arterial CT scan
(mean±SD)
Delayed CT scan (mean±SD)
CTDI (mGy) 3.13±1.27 31.01±9.57 2.32±0.93
DLP (mGycm) 28.1±16.9 458.3±166.7 68.7±46.7
Dose (mSv) 0.41±0.23 6.65±2.42 1.00±0.68
CTDI CT dose index, DLP dose length product
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0.80. This means there was a good interobserver agreement
for the non-enhanced scan and a good-to-excellent agreement
for the other acquisitions and for scoring image quality of
leaflet motion.
Discussion
Several studies have demonstrated the potential and incremen-
tal value of MDCT in patients with suspected PHV dysfunction
[6–8]. However, these studies used retrospective ECG-gating
CT angiography with a relatively high mean radiation dose of
well over 10 mSv for a single arterial phase acquisition only.
Utilizing the capabilities of a modern dual-source scanner, we
devised a comprehensive multiphase acquisition protocol for
PHV assessment that aims to reduce radiation dose but at the
same time increase coverage and assessment potential in mul-
tiple phases. Our study shows that this acquisition protocol was
associated with good overall image quality and a moderate
radiation dose of 8.3 ±3.0 mSv while making three consecutive
acquisitions. Furthermore, leaflet motion, which is an essential
part of PHVevaluation with CT, could be visualized using the
cine mode with a mean image quality of 3.9±1.4. The use of
three subsequent acquisitions offers a wide range of diagnostic
possibilities and also provides essential information for plan-
ning possible re-interventions. Although the additional acquisi-
tion phases may not necessarily change the diagnosis per se,
they may be helpful in interpretation and increase confidence.
This, however, is difficult to quantify and therefore not included
quantitatively in this study. The first, non-enhanced, scan shows
the presence and extent of (peri)valvular calcifications. In case
of endocarditis, calcifications in pseudoaneurysms around the
aortic root allow discrimination between a chronic instead of an
active endocarditis, as was the case in one of our patients.
Moreover, this non-enhanced scan can identify sutures with
polytetrafluorethylene felt pledgets, which were used in eight
(19 %) of our patients. These pledgets can be isodense to con-
trast and mimic paravalvular leakage on CTA, thus a non-
enhanced scan can be helpful to differentiate between the two
(Fig. 6) [12]. The goal of the second CTA acquisition is to
evaluate valve position and valve dynamics as well as to look
for possible leakage, obstruction, pannus tissue, thrombus or
Fig. 4 Image quality. Example of
CT angiography (CTA)
reconstruction in systole and
diastole showing excellent image
quality of a bi-leaflet prosthetic
heart valve in the aortic position
with valve in open (A) and closed
(B) position
Fig. 5 Patient with aortic prosthetic heart valve (PHV) (TAVR, type
Lotus valve) with suspected endocarditis. CT shows PVL and false
aneurysm formation. A: Axial contrast-enhanced ECG-triggered CT
image shows paravalvular leakage (arrows). B (coronal) and C (sagittal)
contrast-enhanced ECG-triggered CT images nicely show the PHV in the
aortic position and the false aneurysm formation underneath (arrows).
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signs of endocarditis.We used prospective ECG-triggeringwith
three stacks for our CTA acquisition, which lowered the dose
by more than 20 % in comparison to retrospective ECG-
triggering at the cost of a short lack of data in the first 100 ms
after the R-peak of the cardiac cycle [6–8]. By setting the scan
length to exactly 14 cm, three stacks were obtained with
maximum individual stack coverage to ensure images were
without stack artefacts at the level of the valve, as shown by
our results (only two of 44 CTAs had stack artefacts, none of
them affecting the valve). One might consider scanning a single
stack only for the valve. However, the advantage of using three
stacks is that the coronary arteries are completely visualized,
which may allow an additional coronary angiography to be
omitted in case of re-operation. Furthermore, it gives a good
overview of the left ventricular outflow tract. In this acquisition,
we used an ECG-trigger based on absolute millisecond (ms)
time instead of a relative (%) RR-trigger. A ‘scan-on–scan-
off’ padding setting from 0–1,500 ms with 50–500 ms ECG-
pulsing resulted in a scan acquisition window that was guaran-
teed to provide the fastest onset of radiation after an R-peak
(minimum delay is ±100 ms, which is 10 % at 60 bpm).
Radiation was maintained for 1,500 ms (which is a full heart
cycle at 40 bpm) or cut off when the next R-peak occurred. This
meant that regardless of the heart rate, a full heart cycle (starting
from 100 ms) was guaranteed, which makes this protocol very
robust and easy to perform. The higher dose at 50–500 ms
guaranteed high quality systolic images on which pannus,
thrombus and leakage can be evaluated. In diastole, dose was
Fig. 6 The non-contrast scan can
identify sutures with
polytetrafluorethylene felt
pledgets. These pledgets can be
isodense to contrast and mimic
paravalvular leakage (PVL) on
CT angiography (CTA) (A) and a
non-contrast scan (B) can thus be
helpful to differentiate between
the two. Arrow indicates possible
PVL on the CTA and confirms the
hyperdense nature of the pledget
on the non-contrast scan
Fig. 7 Advantage of a delayed
acquisition: differentiating
thrombus from flow artefacts.
One of the advantages of the
delayed scan acquisition is the
ability to better depict thrombus
and differentiate thrombus from
flow artefacts, since patients with
a prosthetic heart valve (PHV)
often have arrhythmias. In the
first patient (A-B), the arterial
C T a n g i o g r a p h y ( C TA )
acquisition (A) depicts a filling
defect in the left atrial appendage
(arrow). The delayed scan (B)
shows that it involved a flow
artefact with good filling of the
left atrial appendage in this phase
(arrows). Thrombus could thus be
excluded. In the second patient
(C-D ) , t h e a r t e r i a l CTA
acquisition (C) also depicts a
filling defect in the left atrial
appendage (arrow). However, in
this case, the delayed scan (D)
confirms the presence of a
thrombus (arrow)
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reduced to 20 % (with higher noise levels), which is tolerable
since this phase is only needed for evaluation of the leaflet
motion and confirmation of pathology detected in systole.
Moreover, prospective triggering reduced prosthetic heart
valve-induced artefacts in comparison with retrospective
ECG-gating [9]. Further development of this protocol could
include automatic kV selection for this CTA acquisition in pa-
tients with a PHV with a limited amount of metallic compo-
nents to further lower radiation dose.
The delayed scan comprised the entire chest and thus the
full thoracic aorta, at a relatively low radiation cost. The ad-
vantages of this ‘add-on’ scan may be the identification of the
extent of disease beyond valves, emphasizing infectious atten-
uation, better depicting thrombus and differentiating thrombus
from flow artefacts (e.g. in the left atrial appendage, since
patients with a PHVoften have arrhythmias). In five patients
(12%) we could thus differentiate between thrombus and flow
artefacts (Fig. 7). Besides optimization of CT acquisition pa-
rameters, another way to achieve dose reduction is to optimize
CT image reconstruction through iterative reconstruction tech-
niques. This alternative image reconstruction method allows
imaging at a lower radiation-dose with similar noise levels and
image quality compared to routine dose filtered back-
projection (FBP), thus reducing dose without compromising
image quality [13].
Although a mean radiation dose of 8.3±3.0 mSv for all
three acquisitions combined is considerably lower than report-
ed previously [6–8], it is not minimal. However, one must take
into account that this patient population was relatively old and
represents a population that often has serious pathology with
relatively high morbidity and mortality, e.g. due to
endocarditis, with a genuine possibility of needing a high-
risk reoperation. This imposes a good balance between low-
ering the radiation dose as much as possible but still gathering
all the information needed for good clinical decision making
and preoperative planning. In follow-up CTexaminations, and
depending on the clinical question, the non-enhanced or de-
layed scan can be omitted and the CTA can be obtained using
only one stack through the valve, where relevant. As
underlined in several recent studies, another additional benefit
of CT is the power to detect leaflet thickening (most likely due
to thrombus formation) of biological and transcatheter PHVs
that was not detected by TTE [14–16]. The possible addition
of CT in the routine work-up early after PHV implantation
also necessitates lowering the radiation dose as much as
possible.
Our study had some limitations. In this descriptive study
of a new CT protocol for the evaluation of PHVs, no com-
parison with other acquisition protocols in the same or a
similar group of patients was made. Furthermore, albeit ir-
relevant to our main outcome of image quality, no compar-
ison with a reference standard was made regarding patho-
logical findings.
Conclusion
A novel comprehensive CT image acquisition protocol is pre-
sented that allows for both dynamic reconstructions to assess
PHV leaflet motion and high-resolution anatomical images
with good image quality, using third-generation dual-source
CT and iterative reconstruction techniques. The moderate ra-
diation dose of 8.3 ±3.0 mSv for this three-phase acquisition is
– albeit not minimal – substantially lower (> 20 % reduction)
than previous (usually retrospectively ECG-gated) single-
phase image acquisition techniques and can be considered
acceptable when seen in relation to the pathology, the risks
and possible re-intervention in this patient population.
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